Found 534 hits.
| 96 | Zuberbier, T.+, Balke, M., Worm, M., Edenharter, G., and Maurer, M.: Epidemiology of urticaria: a representative cross-sectional population survey. Clin. Exp. Dermatol. 2010: 35; 869-873. IF: 1.26 |
| 66 | Staubach, P., Vonend, A., Burow, G., Metz, M., Magerl, M., and Maurer, M.+: Patients with chronic urticaria exhibit increased rates of sensitisation to Candida albicans, but not to common moulds. Mycoses 2008: 52; 334-338. IF: 1.53 |
|
545. |
Richtig, G.+, Berger, M., Koeller, M., Richtig, M., Richtig, E., Scheffel, J., Maurer, M.+, and Siebenhaar, F.+: Perception, impact and use of Beall’s list by the scientific community – a bibliometric big data study. PLoS One 2023:18; e0287547. IF: 2.90 |
o.545
| 274 | Maurer, M.*, Staubach, P.*, Raap, U.*, Richter-Huhn, G.*, Bauer, A., Ruëff, F., Jakob, T., Yazdi, A. S., Mahler, V., Wagner, N., Lippert, U., Hillen, U., Schwinn, A., Pawlak, M., Behnke, N., Chaouche, K., and Chapman-Rothe, N.: H1-antihistamine-refractory chronic spontaneous urticaria: It’s worse than we thought – first results of the multicenter real-life AWARE study. Clin. Exp. Allergy 2017: 47; 684-692. IF: 5.16 |
| 404. | Riedl, M. A.+, Maurer, M., Bernstein, J. A., Banerji, A., Longhurst, H. J., Henry Li, H., Lu, P., Hao, J., Juethner, S., and Lumry, W. R.: Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks. Allergy 2020: 75; 2879-2887. IF: 13.15 |
o.404
| 414. | Kolkhir, P., Altrichter, S., Asero, R., Daschner, A., Ferrer, M., Giménez-Arnau, A., Hawro, T., Jakob, T., Kinaciyan, T., Kromminga, A., Konstantinou, G. N. Makris, M., Metz, M., Stahl Skov, P., Staubach, P., Sussman, G., Zhang, K., and Maurer, M.+: Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria. Allergy Asthma Immunol. Res. 2021: 13; 545-559. IF: 5.10 |
o.414
| 170 | Weller, K., Groffik, A., Magerl, M., Tohme, N., Martus, P., Krause, K., Metz, M., Staubach, P., and Maurer, M.+: Development, validation, and initial results of the angioedema activity score. Allergy 2013: 68; 1185-1192. IF: 5.99 |
| 388. | Weller, K.+, Donoso, T., Magerl, M., Aygören-Pürsün, E., Staubach, P., Martinez-Saguer, I., Hawro, T., Altrichter, S., Krause, K., Siebenhaar, F., Metz, M., Zuberbier, T., Freier, D., and Maurer, M.: Validation of the angioedema control test (AECT) – a patient reported outcome instrument for assessing angioedema control. J. Allergy Clin. Immunol. Pract. 2020: 8; 2050-2057. IF: 8.86 |
o.388
| 233 | Kulthanan, K., Chularojanamontri, L.+, Tuchinda, P., Rujitharanawong, C., Maurer, M. and Weller, K.: Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT). Health Qual. Life Outcomes 2016: 14; 61-70. IF: 2.14 |
| 91 | Młynek, A., Magerl, M., Siebenhaar, F., Weller, K., Vieira dos Santos, R., Zuberbier, T., Zalewska-Janowska, A., and Maurer, M.+: Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Brit. J. Dermatol. 2010: 162; 198-200. IF: 4.35 |